Cite

HARVARD Citation

    Leiva, M. et al. (2017). Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro. Scientific reports. 7 (1), pp. 1-15. [Online]. 
  
Back to record